You probably know someone who has a condition that, until last week, was known as PCOS, or polycystic ovary syndrome. It affects one in eight reproductive-aged women. But despite it being such a common disorder, patients are often misdiagnosed and have delayed treatment. Now, medical professionals are trying to change that. After 15 years of work, the condition has been renamed to PMOS, or polyendocrine metabolic ovarian syndrome. The new name reflects the real driver of the condition: disruptions in hormones. But how much can changing a name really do?  <a href="https://www.mchri.org.au/guidelines-resources/community/pmos-resources-2/"target="_blank" >Click here</a> to access resources about PMOS in multiple languages.  Interested in more science? Email us your question at <a href="mailto:shortwave@npr.org"target="_blank" >shortwave@npr.org</a>. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at <a href="http://plus.npr.org/shortwave"target="_blank" >plus.npr.org/shortwave</a>. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. <a href="https://www.npr.org/about-npr/179878450/privacy-policy">NPR Privacy Policy</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Why renaming this common hormonal disorder is a huge deal

Short Wave Plus

AI Chapters

AI Insights

Reviews